Ligand Pharmaceuticals Inc.

519 articles about Ligand Pharmaceuticals Inc.

• Investigators Present Final Results Of Three Groundbreaking Trials Of Ligand Pharmaceuticals Inc.'s AVINZA(R) At The American Pain Society Meeting

  5/4/2006

• Ligand Pharmaceuticals Inc. Announces Preliminary Unaudited Financial Results For 2005

  3/17/2006

• The Opioid Certification Program Receives Primary Sponsorship Grant From Ligand Pharmaceuticals Inc.

  2/21/2006

• Ligand Pharmaceuticals Inc. To Pay Akzo Nobel N.V.'s Organon Pharmaceuticals USA Inc. To End Deal

  1/18/2006

• Ligand Pharmaceuticals Inc. Files S-1 for Existing Employee & Director Stock Plans

  1/16/2006

• Ligand Pharmaceuticals Inc. Announces Final Results And Filing Of Forms 10Q For First, Second And Third Quarters Of Fiscal 2005

  12/12/2005

• Ligand Pharmaceuticals Inc. And Third Point Reach Agreement

  12/5/2005

• Ligand Pharmaceuticals Inc. Collaborator Drug Shows Encouraging Results In Thrombocytopenia; GlaxoSmithKline Releases Phase II Data; Ligand Drug For Thrombocytopenia Targeted For IND Filing 1H'06

  12/2/2005

• Ligand Pharmaceuticals Inc. To Explore Strategic Alternatives; Engages UBS Investment Bank As Financial Advisor

  11/18/2005

• Ligand Pharmaceuticals Inc. Announces Preliminary Revenue Estimates For Third Quarter Of Fiscal 2005

  11/18/2005

• Third Point LLC To Run Slate Of 8 Nominees For Election To The Board Of Directors Of Ligand Pharmaceuticals Inc.

  11/17/2005

• The Day In Review: Biotech Strong While Market Slides

  4/8/2005

• The Week In Review: Biotech Limps Into 2nd Quarter

  4/4/2005

• The Day In Review: Biotech Slides Lower

  3/27/2005

• Centient Investor Release: Biggest Biotech Winners And Losers During Q3

  10/13/2004

• Are Biotechs Worth The Risk?

  8/9/2004

• Cancer Worries Dog New Anti-Fat Drugs

  7/15/2004

• Drug Tested At OHSU Prevents MS-like Disease In Animals

  6/21/2004

• Lilly, Ligand Move Drug Into Late Stage Trials

  3/2/2004